-
公开(公告)号:US20180023040A1
公开(公告)日:2018-01-25
申请号:US15548602
申请日:2016-03-11
申请人: Evonik Degussa GmbH
摘要: The invention relates to compositions comprising at least one protease and at least one biosurfactant, particularly selected from rhamnolipids and sophorolipids. In particular, the present invention is directed to a composition including A) at least one peptidase, B) at least one biosurfactant, and optionally C) at least one anionic surfactant. The peptidase may be selected from the group of the proteases, particularly from the group of the serine proteases of EC 3.4.21 and the metalloproteases of EC 3.4.24 and the biosurfactant may be selected from the group comprising rhamnolipids and sophorolipids.
-
公开(公告)号:US20170335238A1
公开(公告)日:2017-11-23
申请号:US15520157
申请日:2015-11-09
申请人: Evonik Degussa GmbH
摘要: A rhamnolipid composition including 30% by weight to 70% by weight, of at least one rhamnolipid and 30% by weight to 70% by weight of water, where the percentages by weight refer to the total composition, wherein the pH of the composition at 25° C. is from 5.5 to 7.0. In addition to the foregoing rhamnolipid composition, also set forth is a method to make a solution of rhamnolipids; and a salt of at least one rhamnolipid.
-
公开(公告)号:US11464717B2
公开(公告)日:2022-10-11
申请号:US16470411
申请日:2018-01-31
申请人: Evonik Degussa GmbH
发明人: Hans Henning Wenk , Kathrin Daniela Brandt , Martin Schilling , Verena Dahl , Jochen Kleinen , Joachim Venzmer
摘要: The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.
-
公开(公告)号:US10604722B2
公开(公告)日:2020-03-31
申请号:US15520157
申请日:2015-11-09
申请人: Evonik Degussa GmbH
摘要: A rhamnolipid composition including 30% by weight to 70% by weight, of at least one rhamnolipid and 30% by weight to 70% by weight of water, where the percentages by weight refer to the total composition, wherein the pH of the composition at 25° C. is from 5.5 to 7.0. In addition to the foregoing rhamnolipid composition, also set forth is a method to make a solution of rhamnolipids; and salt of at least one rhamnolipid.
-
公开(公告)号:US20190307657A1
公开(公告)日:2019-10-10
申请号:US16470411
申请日:2018-01-31
申请人: Evonik Degussa GmbH
发明人: Hans Henning Wenk , Kathrin Daniela Brandt , Martin Schilling , Verena Dahl , Jochen Kleinen , Joachim Venzmer
摘要: The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.
-
公开(公告)号:US20190269158A1
公开(公告)日:2019-09-05
申请号:US16332979
申请日:2017-09-29
申请人: Evonik Degussa GmbH
发明人: Martin Schilling , Josef Lorenz , Kathrin Daniela Brandt , Monica Desiree van Logchem , Maciej Olek , Hans Henning Wenk
IPC分类号: A23L3/3517 , A23L3/3544 , A23L3/349 , A23L3/3472
摘要: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.
-
公开(公告)号:US10544384B2
公开(公告)日:2020-01-28
申请号:US15546297
申请日:2016-02-08
申请人: Evonik Degussa GmbH
发明人: Ralph Scheuermann , Marcel Pickl , Michael Ferenz , Hans Henning Wenk , Martin Schilling , Kathrin Daniela Brandt , Verena Dahl
摘要: The invention provides compositions comprising at least one rhamnolipid and at least one siloxane, characterized in that the weight ratio of rhamnolipid to siloxane is from 5,000,000:1 to 100:1, preferably from 500,000:1 to 1000:1, particularly preferably from 25,000:1 to 2500:1. In another embodiment, the invention provides compositions include rhamnolipid in an amount of from 0.5% by weight to 70% by weight, preferably from 2% by weight to 60% by weight, particularly preferably from 3% by weight to 50% by weight, where the percentages by weight refer to the total composition.
-
公开(公告)号:US20180016525A1
公开(公告)日:2018-01-18
申请号:US15546297
申请日:2016-02-08
申请人: Evonik Degussa GmbH
发明人: Ralph Scheuermann , Marcel Pickl , Michael Ferenz , Hans Henning Wenk , Martin Schilling , Kathrin Daniela Brandt , Verena Dahl
摘要: The invention provides compositions comprising at least one rhamnolipid and at least one siloxane, characterized in that the weight ratio of rhamnolipid to siloxane is from 5,000,000:1 to 100:1, preferably from 500,000:1 to 1000:1, particularly preferably from 25,000:1 to 2500:1. In another embodiment, the invention provides compositions include rhamnolipid in an amount of from 0.5% by weight to 70% by weight, preferably from 2% by weight to 60% by weight, particularly preferably from 3% by weight to 50% by weight, where the percentages by weight refer to the total composition.
-
-
-
-
-
-
-